Spontaneous coronary artery dissection in association with cabergoline therapy
Sign Up to like & getrecommendations! Published in 2021 at "BMJ Case Reports"
DOI: 10.1136/bcr-2020-240022
Abstract: Spontaneous coronary artery dissection (SCAD) is a rare but increasingly recognised cause of acute coronary syndrome. While numerous risk factors are associated with SCAD, one potential cause is coronary artery vasospasm. The use of cabergoline—an… read more here.
Keywords: spontaneous coronary; cabergoline therapy; artery; coronary artery ... See more keywords
Start low, go slowly – mental abnormalities in young prolactinoma patients under cabergoline therapy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Pediatric Endocrinology and Metabolism"
DOI: 10.1515/jpem-2018-0475
Abstract: Abstract Background Prolactin-secreting pituitary adenomas in childhood and adolescence are rare. First-line therapy consists of dopamine agonists (DAs) like cabergoline. Experience in treating prolactinomas in paediatric and adolescent patients is limited. Methods This study was… read more here.
Keywords: cabergoline therapy; paediatric adolescent; therapy; adverse effects ... See more keywords
Prolactin ≤1 ng/mL Predicts Macroprolactinoma Reduction after Cabergoline Therapy.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of endocrinology"
DOI: 10.1530/eje-19-0753
Abstract: OBJECTIVE The association between prolactin level variation and prolactinoma size reduction remains unclear. This study aimed to determine the prolactin level cut-off predictive of a tumor size reduction. DESIGN Retrospective cohort study. METHODS We reviewed… read more here.
Keywords: reduction; cabergoline therapy; tumor size; size ... See more keywords